Sino Biopharmaceutical's market cap is currently $18.28B. The company's EPS TTM is $0.026353651999999998; its P/E ratio is 37.05; and it has a dividend yield of 1.10%. Sino Biopharmaceutical is scheduled to report earnings on August 18, 2025, and the estimated EPS forecast is $0.01. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24
Dec 23
Dec 22
Dec 21
Dec 20
Currency in CNY
Sino Biopharmaceutical Earnings and Revenue History
